Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 71 Skin Neoplasms 16 Carcinoma, Basal Cell 15 Lymphoma, T-Cell, Cutaneous 12 Neoplasms 9 Keratosis, Actinic 7 Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 6 Carcinoma, Squamous Cell 6 Carcinoma, Merkel Cell 6 Mycosis Fungoides 5 Colorectal Neoplasms 5 Carcinoma, Renal Cell 5 Breast Neoplasms 5 Uveal Melanoma 4 Sezary Syndrome 4 Neoplasm Metastasis 4 Uterine Cervical Neoplasms 3 Sarcoma 3 Endometrial Neoplasms 3 Urogenital Neoplasms 2 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Testicular Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2

Interventions

vedolizumab 1 Photopheresis 1 Mycophenolic Acid 1 Methoxsalen 1 Infliximab 1 Azathioprine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Hepatitis × Dermatologic × Clear all

NCT07619898 2026-06-02

PHOENIX-ECP

Therakos LLC

Phase 2 Not yet recruiting

Colitis, Hepatitis, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡